Last reviewed · How we verify

NCT03175770

Feasibility of Radiofrequency Resection in Oropharyngeal Tumor Surgery

Completed Last updated 25 March 2020
What this trial tests

trial testing transoral radiofrequency Resection in Oropharyngeal Tumor Surgery in Radiofrequency Resection in 25 participants. Completed in 15 June 2017.

Timeline
1 January 2015
Primary endpoint
1 June 2017
15 June 2017

Quick facts

Lead sponsorTechnical University of Munich
StatusCompleted
Study typeOBSERVATIONAL
Enrollment25
Start date1 January 2015
Primary completion1 June 2017
Estimated completion15 June 2017
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Technical University of Munich

Who can join

18 and older, any sex, with Radiofrequency Resection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the last years radiofrequency resection has become a frequent method in surgical subspecialties. Although many departments are using this method for the resection of Tumor in the oropharynx, there is no study so far which describes feasibility and safety. Goal of this study is to show feasibility and safety of Radiofrequency Resection in Oropharyngeal Tumor Surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Technical University of Munich trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03175770.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing